Abstracts Archive - Page 1963 of 2607 - ACR Meeting Abstracts

Abstract Number: 1382 • 2015 ACR/ARHP Annual Meeting
Clinical and Serum IgG4 Characteristics of a Unique British Columbian IgG4-Related Disease Cohort
Luke Chen¹, Andre Mattman², Sujin Park³, Brian Skinnider⁴, Graham Slack⁴ and Mollie Carruthers⁵, ¹Hematology, University of British Columbia, Vancouver, BC, Canada, ²Medical Biochemistry, University of British Columbia, Vancouver, BC, Canada, ³University of British Columbia, Vancouver, BC, Canada, ⁴Pathology, University of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder that is known to have protean manifestations and variably elevated serum IgG4 concentrations. We present the serum…
Abstract Number: 1383 • 2015 ACR/ARHP Annual Meeting
T-Cell Subset Analysis in IgG4-Related Disease and Lymphocyte-Variant Hypereosinophilic Syndrome
Mollie Carruthers¹, Bakul Dalal², Sujin Park³, Graham Slack², Andre Mattman⁴ and Luke Chen⁵, ¹Rheumatology, University of British Columbia, Vancouver, BC, Canada, ²Pathology, University of British Columbia, Vancouver, BC, Canada, ³University of British Columbia, Vancouver, BC, Canada, ⁴Medical Biochemistry, University of British Columbia, Vancouver, BC, Canada, ⁵Hematology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: IgG4-related disease (IgG4-RD) and lymphocyte-variant hypereosinophilic syndrome (L-HES) share elevated peripheral eosinophilia and IgE levels as well as common clinical features including atopy, cutaneous…
Abstract Number: 1384 • 2015 ACR/ARHP Annual Meeting
Comparison of IgG4-Related and Non-IgG4-Related Retroperitoneal Fibrosis; A 12 Year Retrospective Study
Piyush Poddar^1,2, Steven Billings³, Leonard H. Calabrese⁴ and Carmen E. Gota⁵, ¹Rheumatology, Sanford Medical center, Bismarck, ND, ²Rheumatology, Cleveland Clinic, Cleveland, OH, ³Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, ⁴Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, ⁵Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH
Comparison of IgG4-related and Non-IgG4-related Retroperitoneal fibrosis; a 12 year Retrospective Study Background/Purpose: Retroperitoneal fibrosis (RPF) is a rare disease characterized by a progressive proliferation…
Abstract Number: 1385 • 2015 ACR/ARHP Annual Meeting
Efficacy and Tolerance of Rituximab in IgG4-Related Disease: A Retrospective Multicentric Study in 24 Patients
Mikael Ebbo¹, Aurélie Grados¹, Maxime Samson², Clarisse Carra-Dallière³, Agnieszka Pozdzik⁴, Pierre Labauge³, Sylvain Palat⁵, Jean-Marie Berthelot⁶, Jean-Loup Pennaforte⁷, Alain Wynckel⁸, Celine Lebas⁹, Thomas Quémeneur¹⁰, Karine Dahan¹¹, Jean-Jacques Boffa¹¹, Bertrand Godeau¹², Nicolas Limal¹², Franck Carbonnel¹³, Anne Herber¹⁴, Gaëlle Leroux¹⁵, Patrice Cacoub¹⁶, Alexis Mathian¹⁷, Eric Hachulla¹⁸, Nathalie Costedoat-Chalumeau¹⁹, Jean-Robert Harle²⁰ and Nicolas Schleinitz¹, ¹Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, ²Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, ³Neurology, CHRU de Montpellier, Montpellier, France, ⁴Nephrology, Erasme Hospital, Cliniques Universitaires de Bruxelles, Bruxelles, Belgium, ⁵Service de Medecine Interne, CHU limoges, Limoges, France, ⁶Rhumatologie, CHU Nantes, Nantes, France, ⁷Internal Medicine, CHU de Reims, Reins, France, ⁸Nephrolohy, CHU de Reims, Reims, France, ⁹Nephrology, CHRU de Lille, Lille, France, ¹⁰CH Valenciennes, Valenciennes, France, ¹¹Nephrology, Tenon Hospital, Paris, France, ¹²Internal Medicine, Mondor Hospital, Creteil, France, ¹³Gastro-enterology, CHU Bicêtre, Le Kremlin Bicêtre, France, ¹⁴Gastro-enterology, CH de Chartres, Chartres, France, ¹⁵Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, ¹⁶Internal Medicine Department, University Hospital “Pitié-Salpêtrière”, “Pierre et Marie Curie Paris VI” University, Paris, France, ¹⁷Internal Medecine Department, Pitie-Salpetriere Hospital, Paris, France, ¹⁸FAI²R, Hôpital Claude Huriez, CHRU Lille, LILLE, France, ¹⁹Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, ²⁰Internal Medicine, Aix-Marseille Université, APHM, Marseille, France
Background/Purpose: IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition with characteristic histopathological lesions. Nearly all anatomic sites can be involved with a risk of organ…
Abstract Number: 1386 • 2015 ACR/ARHP Annual Meeting
Malignancy Prevalence Is Increased Among Patients before the Onset of IgG4-Related Disease
Zachary Wallace¹, John H. Stone², Hyon K. Choi³, Na Lu³ and Carly Wallace⁴, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, ³Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴Rheumatology Unit, Massachusetts General Hospital, Boston, MA
Background/Purpose: IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory disease of unclear etiology. Studies have suggested that patients with IgG4-RD may be at increased risk of…
Abstract Number: 1387 • 2015 ACR/ARHP Annual Meeting
Thoracic Paravertebral Masses and IgG4-Related Disease: Report of 8 Cases and Review of the Literature
Zachary Wallace¹, Sian Lim¹, John H. Stone², Micheal McInnis³ and Amita Sharma⁴, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, ³Radiology Department, Thoracic Imaging, Massachusetts General Hospital, Boston, MA, ⁴Department of Radiology, Thoracic Imaging, Massachusetts General Hospital, Boston, MA
Background/Purpose: IgG4-related disease (IgG4-RD) is an immune-mediated fibro-inflammatory condition that often leads to tumefactive lesions. We describe a common but under-recognized radiologic finding in this…
Abstract Number: 1388 • 2015 ACR/ARHP Annual Meeting
Adalimumab in Patients with Inactive, Non-Infectious Uveitis Requiring Systemic Treatment
Quan Dong Nguyen¹, Shree Kumar Kurup², Pauline Merrill³, John Sheppard⁴, Joachim Van Calster⁵, Andrew D Dick⁶, Glenn Jaffe⁷, Friederike Mackensen⁸, James T. Rosenbaum^9,10, Ariel Schlaen¹¹, Anne Camez¹², Samir Tari¹³, Martina Kron¹², Alexandra Song¹³ and Antoine Brezin¹⁴, ¹Truhlsen Eye Institute, University of Nebraska, Omaha, NE, ²Wake Forest Baptist Medical Center, Winston-Salem, NC, ³Rush University Medical Center, Chicago, IL, ⁴Lions Medical Eye Bank of Eastern Virginia, Norfolk, VA, ⁵University Hospitals Leuven, Leuven, Belgium, ⁶Bristol Eye Hospital, Bristol, United Kingdom, ⁷Duke University, Durham, NC, ⁸Heidelberg University Hospital, Heidelberg, Germany, ⁹Dever's Eye Institute, Legacy Hospital, Portland, OR, ¹⁰Division of Rheumatology, Oregon Health and Science University, Portland, OR, ¹¹Austral University, Buenos Aires, Argentina, ¹²Abbvie Deutschland GmbH & Co KG, Ludwigshafen, Germany, ¹³AbbVie Inc., North Chicago, IL, ¹⁴Université Paris Descartes, Hôpital Cochin, Paris, France
Background/Purpose: To assess adalimumab (ADA) efficacy and safety in corticosteroid-dependent patients with inactive non-infectious, intermediate, posterior, or panuveitis enrolled in the international, double-masked trial, VISUAL…
Abstract Number: 1389 • 2015 ACR/ARHP Annual Meeting
A Meta-Analysis of the Prevalence of the Ocular Manifestations in All Inflammatory Rheumatic Diseases
Jacqueline Hayworth¹ and Janet E. Pope², ¹Medicine, University of Western Ontario and U of Toronto, Toronto, ON, Canada, ²University of Western Ontario, London, ON, Canada
Background/Purpose: Many inflammatory rheumatic diseases (IRD) are associated with ocular involvement. The prevalence of these complications is not fully known. This meta-analysis was performed to…
Abstract Number: 1390 • 2015 ACR/ARHP Annual Meeting
Hidradenitis Suppuritiva Is Associated with Inflammatory Eye Disease
Abrahim U. Syed¹, Didem Uzunaslan², Careen Y. Lowder³, Sunil Srivastava³, Juan J. Maya¹ and Rula A Hajj-Ali⁴, ¹Internal Medicine, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Cleveland, OH, ³Cole Eye Institute, Cleveland Clinic, Cleveland, OH, ⁴Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Hidradenitis Suppurativa (HS) is an inflammatory skin condition that can cause profound morbidity. Patients can present with recurrent nodules, sinus tract formation, abscesses and/or…
Abstract Number: 1391 • 2015 ACR/ARHP Annual Meeting
Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds
Anirban Banerjee¹, Victoria K. Shanmugam^1,2, Sean McNish¹ and Kara Couch¹, ¹Division of Rheumatology, The George Washington University, Washington, DC, ²Director, Division of Rheumatology, The George Washington University, Washington, DC
Background/Purpose: Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory disease which affects 1% to 4% of young adults. The purpose of the current study was…
Abstract Number: 1392 • 2015 ACR/ARHP Annual Meeting
Azathioprine May be an Effective Steroid Sparing Agent in Patients with Isolated Recurrent Pericarditis
Adam Brown¹, Xiaobo Liu² and Soumya Chatterjee³, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ³Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose: Isolated Recurrent pericarditis (IRP) is a disease with high morbidity. IRP refers to recurrent pericarditis not associated with an autoimmune rheumatic disease or cardiac…
Abstract Number: 1393 • 2015 ACR/ARHP Annual Meeting
Diagnostic Categorization of Ocular Sarcoidosis Based on the International Criteria Proposed By the First International Workshop on Ocular Sarcoidosis. a Case Series of 11 Spanish Patients
Carlos Francisco Meneses Villalba¹, Olga Maiz Alonso¹, Ana Blanco², César Antonio Egües Dubuc¹, Miren Uriarte Ecenarro¹, Nerea Errazquin Aguirre¹, Jesus A. Valero¹ and Joaquin Maria Belzunegui Otano¹, ¹Rheumatology, Donostia University Hospital, Donostia, Spain, ²Ophthalmology, Donostia University Hospital, Donostia, Spain
Background/Purpose: Sarcoidosis is a multisystemic disorder of unknown cause. About 30-60% of patients have ocular involvement consistent in bilateral uveitis. Recently, the clasification criteria proposed by…
Abstract Number: 1394 • 2015 ACR/ARHP Annual Meeting
Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study
Patompong Ungprasert¹, Cynthia S. Crowson² and Eric L. Matteson³, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: The epidemiology and clinical characteristics of sarcoid arthropathy are not well-described as only referral-based studies have been reported. This study aimed to use the…
Abstract Number: 1395 • 2015 ACR/ARHP Annual Meeting
Prevalence and Significance of MEFV GENE Mutations in Patients with Sarcoidosis
Senol Kobak¹, Fidan Sever², Ozlem Goksel³, Tuncay Goksel³, Mehmet Orman⁴ and Afig Berdeli⁵, ¹Rheumatology, Sifa University Faculty of Medicine, 35100, Turkey, ²Chest Disease, Sifa University, Izmir, Turkey, ³Chest Disease, Ege University, Izmir, Turkey, ⁴Ege University Department of Statistic, Associated Professor, Izmir, Turkey, ⁵Genetics and Molecular Medicine, Ege University, Izmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous disease. Pyrin, is encoded by the MEFV gene and has anti-inflammatory effects in the inflammasoma regulation. MEFV gene mutations…
Abstract Number: 1396 • 2015 ACR/ARHP Annual Meeting
Long Term Outcome of Neurosarcoidosis
Catherine Chapelon¹, Bastien Joubert¹, Lucie Biard², David Saadoun³, Mathieu Resche Regon⁴, Fanny Domont¹, Lea Savey¹, Didier Dormont¹ and Patrice Cacoub⁵, ¹Hôpital Pitié Salpétrière, AP-HP, UPMC, Univ Paris 06, Paris, France, ²Biostatistics, Saint-Louis Hospital, Paris, France, ³Department of Internal Medicine and clinical Immunology. French National Reference Center for Autoimmune Diseases. DHU I2B (Inflammation, Immunotherapy and Biotherapy), UPMC, Paris VI, Hôpital Pitié Salpétrière, AP-HP, UPMC, Univ Paris 06, Paris, France, ⁴biostatistics Saint Louis Hospital, paris, France, ⁵Internal Medicine Department, University Hospital “Pitié-Salpêtrière”, “Pierre et Marie Curie Paris VI” University, Paris, France
Background/Purpose: Although clinical and imaging features of neurosarcoidois (NS) have been described, few studies have reported on the long-term outcome. We report the long-term outcome…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].